US Patent Issued to BEIJING QL BIOPHARMACEUTICAL on Sept. 1 for "Pharmaceutical compositions of polypeptide conjugates and methods of uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,897, issued on Sept. 1, was assigned to BEIJING QL BIOPHARMACEUTICAL Co. LTD. (Beijing).

"Pharmaceutical compositions of polypeptide conjugates and methods of uses thereof" was invented by Yuanyuan Zhang (Beijing), Hongyu Shi (Beijing), Xiaona Dong (Beijing), Peng Zhai (Beijing) and Hongzhou Dong (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides polypeptide conjugates comprising GLP-1 receptor agonist and a peptide linker, and pharmaceutical compositions comprising the same. Methods of using such for treating diseases are also provided."

The patent was filed on Nov. 3, 2023, under Application No. 18/501,061.

*...